NO20055766L - Positive modulatorer av nikotinacetylcholinreseptorer - Google Patents
Positive modulatorer av nikotinacetylcholinreseptorerInfo
- Publication number
- NO20055766L NO20055766L NO20055766A NO20055766A NO20055766L NO 20055766 L NO20055766 L NO 20055766L NO 20055766 A NO20055766 A NO 20055766A NO 20055766 A NO20055766 A NO 20055766A NO 20055766 L NO20055766 L NO 20055766L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- acetylcholine receptors
- positive modulators
- nicotine acetylcholine
- formula
- Prior art date
Links
- POPPVIRYGJQIOF-UHFFFAOYSA-N 2-acetyloxyethyl(trimethyl)azanium;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound CC(=O)OCC[N+](C)(C)C.CN1CCCC1C1=CC=CN=C1 POPPVIRYGJQIOF-UHFFFAOYSA-N 0.000 title 1
- 108010009685 Cholinergic Receptors Proteins 0.000 title 1
- 102000034337 acetylcholine receptors Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract 1
- 230000005540 biological transmission Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960002715 nicotine Drugs 0.000 abstract 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000009467 reduction Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0301320A SE0301320D0 (sv) | 2003-05-06 | 2003-05-06 | Positive modulators of nicotinic acetylcholine receptors |
| PCT/GB2004/001934 WO2004098600A1 (en) | 2003-05-06 | 2004-05-04 | Positive modulators of nicotinic acetylcholine receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20055766L true NO20055766L (no) | 2005-12-05 |
Family
ID=20291221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055766A NO20055766L (no) | 2003-05-06 | 2005-12-05 | Positive modulatorer av nikotinacetylcholinreseptorer |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070179172A1 (de) |
| EP (1) | EP1631288A1 (de) |
| JP (1) | JP2006525302A (de) |
| KR (1) | KR20060009899A (de) |
| CN (1) | CN1784230A (de) |
| AU (1) | AU2004237130A1 (de) |
| BR (1) | BRPI0410050A (de) |
| CA (1) | CA2524019A1 (de) |
| MX (1) | MXPA05011785A (de) |
| NO (1) | NO20055766L (de) |
| SE (1) | SE0301320D0 (de) |
| WO (1) | WO2004098600A1 (de) |
| ZA (1) | ZA200508860B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005284908B2 (en) | 2004-09-13 | 2011-12-08 | Morningside Venture Investments Limited | Biosynchronous transdermal drug delivery |
| US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| FR2884822B1 (fr) * | 2005-04-22 | 2007-06-29 | Aventis Pharma Sa | Derives de triazines, leur preparation et leur application en therapeutique |
| DE102005027169A1 (de) * | 2005-06-13 | 2006-12-14 | Merck Patent Gmbh | Tetrahydrochinolinderivate |
| US20080214537A1 (en) * | 2007-03-02 | 2008-09-04 | Cara Therapeutics, Inc. | Bridged phenanthridines |
| CN103977003A (zh) * | 2007-04-02 | 2014-08-13 | 帕金森氏病研究院 | 用于降低治疗的副作用的方法和组合物 |
| US8383657B2 (en) | 2007-12-21 | 2013-02-26 | Abbott Laboratories | Thiazolylidine urea and amide derivatives and methods of use thereof |
| WO2013006643A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
| EP2647628A1 (de) * | 2012-04-02 | 2013-10-09 | Almirall, S.A. | Substituierte tricyclische Verbindungen mit Aktivität gegenüber EP1-Rezeptoren |
| EP2876109A4 (de) * | 2012-07-23 | 2016-03-16 | Yuhan Corp | Kondensierte ringverbindung mit furan-oder einem salz davon sowie pharmazeutische zusammensetzungen damit |
| WO2016014847A1 (en) * | 2014-07-23 | 2016-01-28 | Northeastern University | Ligands for alpha-7 nicotinic acetylcholine receptors and methods of treating neurological and inflammatory conditions |
| AU2016211330A1 (en) | 2015-01-28 | 2017-08-03 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
| US10679516B2 (en) | 2015-03-12 | 2020-06-09 | Morningside Venture Investments Limited | Craving input and support system |
| CA3049529A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
| CN107991409B (zh) * | 2017-11-28 | 2020-04-24 | 中国医学科学院肿瘤医院 | 采用高效合相色谱同时测定血浆中12种磺胺类药物的方法 |
| US11596779B2 (en) | 2018-05-29 | 2023-03-07 | Morningside Venture Investments Limited | Drug delivery methods and systems |
| US12397141B2 (en) | 2018-11-16 | 2025-08-26 | Morningside Venture Investments Limited | Thermally regulated transdermal drug delivery system |
| JP2023533016A (ja) | 2020-07-11 | 2023-08-01 | ファイザー・インク | 抗ウイルス性ヘテロアリールケトン誘導体 |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3631050A (en) * | 1968-11-13 | 1971-12-28 | Parke Davis & Co | Hexahydro-9b-methylfuro(3 2-c) quinoline compounds |
| JPS63225358A (ja) * | 1986-10-31 | 1988-09-20 | Sumitomo Pharmaceut Co Ltd | シクロペンタ〔ｂ〕キノリン誘導体 |
| WO1998027427A1 (en) * | 1996-12-18 | 1998-06-25 | Eli Lilly And Company | Combinatorial process for preparing tetrahydroquinoline libraries |
| US5925527A (en) * | 1997-02-04 | 1999-07-20 | Trega Biosciences, Inc. | Tricyclic Tetrahydroquinoline derivatives and tricyclic tetrahydroquinoline combinatorial libraries |
| DE10137488A1 (de) * | 2001-08-03 | 2003-02-20 | Gruenenthal Gmbh | Salze substituierter 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate |
-
2003
- 2003-05-06 SE SE0301320A patent/SE0301320D0/xx unknown
-
2004
- 2004-05-04 KR KR1020057021042A patent/KR20060009899A/ko not_active Withdrawn
- 2004-05-04 WO PCT/GB2004/001934 patent/WO2004098600A1/en not_active Ceased
- 2004-05-04 US US10/553,915 patent/US20070179172A1/en not_active Abandoned
- 2004-05-04 EP EP04731052A patent/EP1631288A1/de not_active Ceased
- 2004-05-04 AU AU2004237130A patent/AU2004237130A1/en not_active Abandoned
- 2004-05-04 MX MXPA05011785A patent/MXPA05011785A/es not_active Application Discontinuation
- 2004-05-04 BR BRPI0410050-6A patent/BRPI0410050A/pt not_active IP Right Cessation
- 2004-05-04 JP JP2006506220A patent/JP2006525302A/ja active Pending
- 2004-05-04 CA CA002524019A patent/CA2524019A1/en not_active Abandoned
- 2004-05-04 CN CNA2004800123148A patent/CN1784230A/zh active Pending
-
2005
- 2005-11-01 ZA ZA200508860A patent/ZA200508860B/en unknown
- 2005-12-05 NO NO20055766A patent/NO20055766L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1631288A1 (de) | 2006-03-08 |
| JP2006525302A (ja) | 2006-11-09 |
| US20070179172A1 (en) | 2007-08-02 |
| BRPI0410050A (pt) | 2006-04-25 |
| SE0301320D0 (sv) | 2003-05-06 |
| AU2004237130A1 (en) | 2004-11-18 |
| MXPA05011785A (es) | 2006-01-26 |
| WO2004098600A1 (en) | 2004-11-18 |
| CN1784230A (zh) | 2006-06-07 |
| CA2524019A1 (en) | 2004-11-18 |
| ZA200508860B (en) | 2007-03-28 |
| KR20060009899A (ko) | 2006-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20055766L (no) | Positive modulatorer av nikotinacetylcholinreseptorer | |
| NO20061657L (no) | Pyrolderivater med antibakteriell aktivitet | |
| NO20074703L (no) | Antibakterielle piperidinderivater | |
| NO20065904L (no) | Terapeutiske forbindelser | |
| TW200615266A (en) | Organic compounds | |
| NO20064201L (no) | Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling | |
| NO20062704L (no) | Azabicykliske heterocykler som cannabinoide reseptormodulatorer | |
| NO20062583L (no) | Difenylazetidinonderivater med kolesterolabsorpsjonsinhiberende aktivitet | |
| IL176110A0 (en) | Azabicyclic heterocycles as cannabinoid receptor modulators | |
| NO20062591L (no) | Difenylazetidinonderivater med kolesterolabsorpsjonsinhiberende aktivitet | |
| TW200716628A (en) | Novel compounds | |
| NO20061839L (no) | Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav | |
| NO20076357L (no) | Azabicykliske heterocykler som cannabinoid reseptor modulatorer | |
| NO20072089L (no) | Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav | |
| DE60322417D1 (en) | 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1,8-naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren | |
| NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| NO20052182L (no) | Nye forbindelser | |
| NO20063619L (no) | Diarylmetylpiperazinderivater, fremstilling og anvendelse derav | |
| MY139613A (en) | Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders | |
| NO20053805L (no) | Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav | |
| NO20062307L (no) | Spirofuropyridinarylderivater | |
| NO20073547L (no) | Nikotinacetykolinreseptorligander | |
| NO20064074L (no) | Pyrrolokinolin- og piperidinokinolinderivater, fremstilling derav, sammensetninger inneholdende disse og anvendelse derav | |
| NO20063618L (no) | Diarylmetylpiperidinderivater, fremstilling og anvendelse derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |